Alimentary Pharmacology & Therapeutics

Do we need a new gastro-oesophageal reflux disease questionnaire?
pp. 463-479(17)
Authors: Stanghellini, V.; Armstrong, D.; Mönnikes, H.; Bardhan, K. D.

The management of pelvic floor disorders
pp. 481-495(15)
Authors: Cheung, O.; Wald, A.

Green tea and gastrointestinal cancer risk
pp. 497-510(14)
Authors: Borrelli, F.; Capasso, R.; Russo, A.; Ernst, E.

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease
pp. 511-519(9)
Authors: Louis, E.; El Ghoul, Z.; Vermeire, S.; Dall'Ozzo, S.; Rutgeerts, P.; Paintaud, G.; Belaiche, J.; De Vos, M.; Van Gossum, A.; Colombel, J. -F.; Watier, H.

Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro
pp. 521-527(7)
Authors: Langmead, L.; Makins, R. J.; Rampton, D. S.

Quality of life in patients with established inflammatory bowel disease: a UK general practice survey
pp. 529-535(7)
Authors: Rubin, G. P.; Hungin, A. P. S.; Chinn, D. J.; Dwarakanath, D.

Metformin in the treatment of patients with non-alcoholic steatohepatitis
pp. 537-544(8)
Authors: Uygun, A.; Kadayifci, A.; Isik, A. T.; Ozgurtas, T.; Deveci, S.; Tuzun, A.; Yesilova, Z.; Gulsen, M.; Dagalp, K.

Correlation of percutaneous liver biopsy fragmentation with the degree of fibrosis
pp. 545-549(5)
Authors: Malik, A. H.; Kumar, K. S.; Malet, P. F.; Jain, R.; Prasad, P.; Ostapowicz, G.

Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy
pp. 551-562(12)
Authors: Apolinario, A.; Diago, M.; Lo Iacono, O.; Lorente, R.; Pérez, C.; Majano, P. L.; Clemente, G.; García-Monzón, C.

Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1-year controlled trial
pp. 563-570(8)
Authors: Pereira, S. P.; O'Donohue, J.; Moniz, C.; Phillips, M. G.; Abraha, H.; Buxton-Thomas, M.; Williams, R.

Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding
pp. 571-581(11)
Authors: Raines, D. L.; Dupont, A. W.; Arguedas, M. R.

Protein-predominant meals inhibit the development of gastric tachyarrhythmia, nausea and the symptoms of motion sickness
pp. 583-590(8)
Authors: Levine, M. E.; Muth, E. R.; Williamson, M. J.; Stern, R. M.

High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis
pp. 591-600(10)
Authors: Barkun, A. N.; Herba, K.; Adam, V.; Kennedy, W.; Fallone, C. A.; Bardou, M.

Lipase inhibition by orlistat: effects on gall-bladder kinetics and cholecystokinin release in obesity
pp. 601-611(11)
Authors: Mathus-Vliegen, E. M. H.; Van Ierland-Van Leeuwen, M. L.; Terpstra, A.

Helicobacter species in human colon biopsies
pp. 613-614(2)
Authors: Sturegård, E.; Hertervig, E.; Sjunnesson, H.; Wadström, T.

Erratum
pp. 615-615(1)